2009-2011
Neuroprotective effect of Nrf2/ARE activators, CDDO-ethylamide and CDDO-trifluoroethylamide in a mouse model of amyotrophic lateral sclerosis. Free Radic Biol Med 51:88-96, 2011. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109235/
The synthetic triterpenoid CDDO-imidazolide suppresses experimental liver metastasis. Clin Exp Metastasis 28:309-317, 2011. https://mct.aacrjournals.org/content/6/11_Supplement/C21
Synthetic triterpenoids prolong survival in a transgenic mouse model of pancreatic cancer. Cancer Prev Res 3:1427-1434, 2010. https://pubmed.ncbi.nlm.nih.gov/20959520/
Anti-inflammatory triterpenoid blocks immune suppressive function of MDSCs and improves immune response in cancer. Clin Cancer Res16:1812-1823, 2010. https://pubmed.ncbi.nlm.nih.gov/20215551/
Triterpenoids, CDDO-methylester or CDDO-ethylamide and rexinoids, LG 100268 or NRX194204 for prevention and treatment of lung cancer in mice. Cancer Prev Res 2:1050-1058, 2009. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2818234/
